Zopiclone and Ataxia aggravated - a phase IV clinical study of FDA data
Ataxia aggravated is found among people who take Zopiclone, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Zopiclone and have Ataxia aggravated. It is created by eHealthMe based on reports of 34,337 people who have side effects when taking Zopiclone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
34,337 people reported to have side effects when taking Zopiclone.
Among them, 181 people (0.53%) have Ataxia aggravated.
What is Zopiclone?
Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 35,866 Zopiclone users for its effectiveness, alternative drugs and more.
What is Ataxia aggravated?
Ataxia aggravated (serious loss of full control of bodily movements) is found to be associated with 649 drugs and 228 conditions by eHealthMe.
Number of Zopiclone and Ataxia aggravated reports submitted per year:
Time on Zopiclone when people have Ataxia aggravated *:
Gender of people who have Ataxia aggravated when taking Zopiclone*:
Age of people who have Ataxia aggravated when taking Zopiclone *:
Common drugs people take besides Zopiclone *:
Common side effects people have besides Ataxia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Zopiclone and have Ataxia aggravated?Check whether Ataxia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Lai SW, Lai HC, Lin CL, Liao KF, "Zopiclone use associated with increased risk of acute pancreatitis: a case–control study in Taiwan", International journal of clinical practice, 2015 Nov .
Alternative drugs to, pros and cons of Zopiclone:
- Zopiclone (35,866 reports)
Ataxia aggravated treatments and more:
- Ataxia aggravated (6 reports)
COVID vaccines that are related to Ataxia aggravated:
- Ataxia aggravated in Moderna COVID Vaccine
- Ataxia aggravated in Pfizer BioNTech Covid Vaccine
- Ataxia aggravated in Johnson and Johnson Covid Vaccine
How severe was Ataxia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of eszopiclone:
Common drugs associated with Ataxia aggravated:
All the drugs that are associated with Ataxia aggravated:
- Ataxia aggravated (649 drugs)
Common conditions associated with Ataxia aggravated:
All the conditions that are associated with Ataxia aggravated:
- Ataxia aggravated (228 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on eszopiclone (the active ingredients of Zopiclone) and Zopiclone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Plaquenil and Coagulation Time Prolonged - 9 seconds ago
- Back Pain and Skin Sensitisation - 44 seconds ago
- Nexium Iv and Klonopin drug interaction - 48 seconds ago
- Methotrexate and Adenocarcinoma Pancreas - 59 seconds ago
- Rivastigmine Tartrate and Vitamin C drug interaction - 59 seconds ago